The Unholy Alliance
Part Two
By Kathleen Deoul
( Page: 17 of 17)
The truth is that with a national board whose
membership is substantially comprised of oncologists, radiologists and others
who derive their income from conventional therapies to treat cancer, these
organizations have a vested financial interest in maintaining the status quo.
For organizations like the American Cancer Society Foundation whose board
includes senior executives of major pharmaceutical/chemical firms, the conflict
is even more evident.
The impact of their influence is apparent. Why else
would the established anticancer organizations only advocate the therapies that
benefit Big Pharma and Organized Medicine while attacking alternatives? Why else
would these same groups ignore the increasingly apparent link between
environmental contamination and cancer? Why else would they virtually ignore
prevention? The simple truth is that they don't want to jeopardize their power,
position and privilege. Of course, with salary and benefit packages in excess of
half a million dollars, like the one the president of the American Cancer
Society has, there's a pretty large personal stake in the status quo.
The Unholy Alliance [Part Two]
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17
The Unholy Alliance [Part One]
Contact
Kathleen Deoul, Media Matters
Email:
admin@cancer-coverup.com
|
Click here to order
